5 billion people have access to medicine 2 billion to go

Mission

The Access to Medicine Foundation stimulates and guides pharmaceutical companies to do more for the people living in low- and middle-income countries without access to medicine.

Who we are
What we analyse
How we drive change

Worldwide, preventable diseases still cost millions of lives each year. The Access to Vaccines Index will reveal how eight key vaccine companies are improving access to vaccines for 69 diseases in 107 countries. It analyses company practice in three areas:

  • Research & Development
  • Pricing & Registration
  • Manufacturing & Supply

News and Events

Out in March: the first Access to Vaccines Index

14 Feb 2017
The first Access to Vaccines Index will be published on Monday 6 March, 2017. It is the first tool of its kind to present the current landscape of vaccine company behaviour when it comes to making vaccines more accessible for the populations that need them.

Foundation to track pharma company progress on AMR

13 Dec 2016
The Access to Medicine Foundation has started work on a new tool – an Antimicrobial Resistance Benchmark that will track how pharmaceutical companies are responding to the increase in drug-resistance. The AMR Benchmark is currently funded by the UK and Dutch governments.

New analysis: large pharmaceutical companies are developing five HIV/AIDS medicines for children

29 Nov 2016
For World AIDS Day 2016, the Access to Medicine Foundation has analysed the pharmaceutical pipelines for HIV/AIDS from 20 of the world’s largest pharmaceutical companies. Out of 51 high-burden diseases and conditions, HIV/AIDS is one of the five diseases getting the most R&D attention. Today, they have five projects in the pipeline aimed at children.

Which pharmaceutical companies have the most essential medicines and vaccines?

08 Nov 2016
The new analysis by the Access to Medicine Foundation shows which large pharmaceutical companies are marketing the most essential medicines and vaccines for the highest-burden disease in developing countries. It matches companies’ on market portfolio for 50 conditions and diseases with the WHO Model Essential Medicine List.

AMR and Access to Cancer Medicine, discussing the role of the pharma industry

20 Sep 2016
Jayasree K. Iyer will participate in two key events on the role of the pharmaceutical industry regarding access to antimicrobials and AMR, and in improving access to cancer medication. She will speak at the UN General Assembly side event on AMR; and at the Royal Society of Medicine on access to cancer medicine.
Access to Medicine Index Cover

Access to Medicine Index 2016

The only in-depth comparison of the world’s largest pharma companies on how they improve access to medicine for the poor.

Visit website

Access to Vaccines Index Cover

Access to Vaccine Index 2017

The first tool to show how vaccine companies are responding to calls to increase access to vaccines.

Visit website

Join our team

Positions in Research, Finance, Strategy
Interested in working toward the next Access to Medicine Index or on our new AMR Benchmark? Or in joining the Foundation’s Finance and Strategy teams?

Investors

Access to medicine: a material issue for investors
Investors engage with the Foundation for insight into our analysis of the pharma sector, including into governance structures, R&D and pricing strategies.

The foundation on Twitter

Clarke Cole's Twitter avatar
Clarke Cole
@clarkebcole

Discussing collaborative R&D of #vaccines for emerging infections at CEPI Scientific Community Meeting @CEPIvaccines @ATMI #ATVI2017

Retweeted by Access to Medicine
Access to Medicine's Twitter avatar
Access to Medicine
@AtMIndex

Only 2 weeks to go! The Access to Vaccines Index will be published on 6th March, 2017. #ATVI2017 #vaccinest.co/3CYZxcxH4R

Access to Medicine's Twitter avatar
Access to Medicine
@AtMIndex

2 weeks to go! The first Access to Vaccines Index will be published on Monday 6 March, 2017. #ATVI2017 #vaccinest.co/nY7AoVPMPP

Access to Medicine's Twitter avatar
Access to Medicine
@AtMIndex

The first Access to Vaccines Index will be published on Monday 6 March, 2017. #ATVI2017 #vaccinest.co/AO0ZHVCXst

Access to Medicine's Twitter avatar
Access to Medicine
@AtMIndex

Out on 6 March: the first Access to Vaccines Index. #ATVI2017 #vaccines t.co/LIkjaakJQY t.co/UznfFh2iR9

Encourage pharma companies Access to Medicine

Commentary

Incentivising pharma to develop medicine for the poor
Which mechanisms work for engaging pharma companies in R&D for diseases of poverty?

“To improve access, we believe pharmaceutical companies need to focus on how
they deploy their products, and, as global citizens, collaborate on the development of strong health systems.”

Jayasree K. Iyer, Executive Director, Access to Medicine Foundation.

1

Embedding pro-access governance

2

Mainstreaming inclusive business models

3

Improving industry responsiveness to public health priorities

4

Employing ‘access-thinking’ in product deployment

5

Addressing unmet needs through R&D

The Access to Medicine Foundation and its publications are funded by

Ukaid
Gates-foundation
Ministry-of-foreign-affairs-of-the-netherlands
Postcode-loterij